$IMA

Lally Robert B sold $17K of IMA

Lally Robert B (Principal Accounting Officer) sold 3,196 shares of ImageneBio, Inc. (IMA) at an average of $5.42 ($5.34–$5.50) across 2 trades over 2026-07-16 to 2026-07-17.

Original reporting
SEC EDGAR · Lally Robert B
Published Jul 21, 2026, 1:47 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 2:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IMA
Neutral
medium confidence
Mentioned
$IMA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IMANeutralLow
01

Why it matters

The disclosure updates insider trading records and may marginally influence sentiment, but it does not introduce new operational or financial information about ImageneBio.

02

Market read

Traders may note the insider sale timing and absence of a 10b5-1 plan, but there is no new fundamental catalyst.

03

What to watch

The article provides no context on total insider holdings, compensation structure, or whether other insiders sold/bought around the same period.

Relevance 3/10Novelty 4/10Timing: Filed 2026-07-20 for sales executed 2026-07-16 to 2026-07-17.

Background

The article is an SEC Form 4 insider transaction disclosure for ImageneBio, Inc.

Company-level read

Ticker impact

$IMANeutralMedium confidence
Context

Form 4 shows ImageneBio principal accounting officer Lally Robert B sold 3,196 shares in open-market trades at about $5.34 to $5.50.

Expected impact

Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is small relative to typical market cap context and provides no earnings, guidance, or operational change.

Market effects

No clear sector read-across from a single small insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be tax- or diversification-driven and may not reflect negative expectations, especially when the filing lacks any accompanying negative narrative.

Key entities

  • ImageneBio, Inc.

    Company whose Form 4 insider sale is disclosed.

  • Lally Robert B

    Principal Accounting Officer who sold 3,196 shares in open-market transactions.

Related articles

$IMAMed

ImageneBio, Inc. (IMA): Results of Operations and Financial Condition

ImageneBio, Inc. (IMA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d166048dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 ImageneBio Reports Second Quarter 2026 Financial Results SAN DIEGO, Aug. 5, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended June 30,